Molecular Formula | C19H18N2O3 |
Molar Mass | 322.36 |
Density | 1.273±0.06 g/cm3(Predicted) |
Boling Point | 621.1±55.0 °C(Predicted) |
Solubility | DMSO or ethanol: soluble |
pKa | 8.82±0.10(Predicted) |
Storage Condition | Inert atmosphere,Store in freezer, under -20°C |
In vitro study | AG 555 (100 μM) inhibits both the early stages (integration process) and the late stages (viral protein synthesis) in the virus life cycle. Tyrphostins AG555, which blocks Cdk2 activation, induces growth arrest of immortalized cells at G1-S and early S and is very effective in arresting the growth of EGFR overexpressor cells. Tyrphostin AG 555 can selectively suppress BPV-1 transcription through MAP kinase pathway activation and binding of phosphorylated Jun/ATF-2 at a novel intragenic regulatory sequence. Cell Proliferation Assay Cell Line: NIH/3T3 uninfected cells and NIH/3T3-Mo-MuLV chronically infected cells. Concentration: 100 μM. Incubation Time: 1 hour. Result: Inhibited Mo-MuLV proviral DNA integration. |
Safety Description | S22 - Do not breathe dust. S24/25 - Avoid contact with skin and eyes. |
WGK Germany | 3 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.102 ml | 15.511 ml | 31.021 ml |
5 mM | 0.62 ml | 3.102 ml | 6.204 ml |
10 mM | 0.31 ml | 1.551 ml | 3.102 ml |
5 mM | 0.062 ml | 0.31 ml | 0.62 ml |
biological activity | AG-555 (Tyrphostin B46) is a tyrosine kinase inhibitor that interacts directly with topoisomerase I, thus, DNA relaxation is prevented. It inhibits EGFR with an IC50 of 0.7 μm. |
Target | TargetValue EGFR (Cell-free assay) 0.7 μm |
Target | Value |
EGFR (Cell-free assay) | 0.7 μM |
in vitro study | AG 555 (100 μm) and the late stages (viral protein synthesis) in the virus life cycle. Tyrphostins AG555, which blocks Cdk2 activation, induces growth arrest of immortalized cells at G1-S and early S and is very effective in arresting the growth of EGFR overexpressor cells. Tyrphostin AG 555 can selectively suppress BPV-1 transcription through MAP kinase pathway activation and binding phosphorylated Jun/ATF-2 at a novel intragenic regulatory sequence. Cell Proliferation Assay Cell Line: NIH/3T3 uninfected cells and NIH/3T3-Mo-MuLV chronically infected cells. Concentration: 100 μM. Incubation Time: 1 hour. Result: Inhibited Mo-MuLV proviral DNA integration. |
Cell Line: | NIH/3T3 uninfected cells and NIH/3T3-Mo-MuLV chronically infected cells. |
Concentration: | 100 μM. |
Incubation Time: | 1 hour. |
Result: | Inhibited Mo-MuLV proviral DNA integration. |